Gupta Nitesh, Agrawal Sumita, Ish Pranav, Mishra Suruchi, Gaind Rajni, Usha Ganapathy, Singh Balvinder, Sen Manas Kamal, Covid Working Group Safdarjung Hospital
Department of Pulmonary, Critical Care and Sleep Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi.
Department of Pulmonary Medicine, Medipulse Hospital, Jodhpur.
Monaldi Arch Chest Dis. 2020 Apr 10;90(1). doi: 10.4081/monaldi.2020.1294.
COVID-19 has now become a pandemic. It has spread from Wuhan, China, in December 2019 to a large number of countries within three months. The objective of this work is to report the initial experience with epidemiologic and clinical features, as well as with the management of COVID-19 patients in India. This is a descriptive case series of the first 21 COVID-19 infected patients confirmed with polymerase chain reaction (PCR) and admitted to a tertiary care centre in India from 01.02.2020 to 19.03.2020. Clinical, laboratory, and radiologic data were collected, including age, sex, nationality, travel history, symptoms, duration of stay, and comorbidities. The mean age of the population was 40.3 years with a male preponderance. Thirteen (62%) patients had recent travel history outside India in the previous 30 days, two thirds of whom had travelled to Italy. The most common symptoms were fever and cough (42.9%) followed by sore throat, headache and breathlessness. Vital and laboratory parameters were preserved in all patients and none of them required ventilatory support. Among the first 21 patients diagnosed with COVID-19 infection in India, the typical clinical presentation consisted in a mild upper respiratory tract infection predominantly affecting the young male population. One patient required supplemental oxygen. All patients recovered with no residual symptoms. *The Safdarjung Hospital COVID 2019 working group: Nitesh Gupta, Sumita Agrawal, Pranav Ish, Suruchi Mishra, Rajni Gaind, Ganapathy Usha, Balvinder Singh, Manas Kamal Sen, Shibdas Chakrabarti (Consultant and Head, Pulmonary Medicine); NK Gupta (Professor, Pulmonary medicine); Dipak Bhattacharya (Consultant, Pulmonary medicine); Rohit Kumar (Assistant Professor, Pulmonary Medicine); Siddharth R. Yadav (Assistant Professor, Pulmonary Medicine); Rushika Saksena (Specialist, Microbiology); Rojaleen Das (Assistant Professor, Microbiology); Vikramjeet Dutta (Assistant Professor, Microbiology); Anupam Kr Anveshi (Senior Resident, Microbiology); Santvana Kohli (Assistant Professor, Anaesthesiology); Naveen KV (Assistant Professor, Anaesthesiology); Amandeep Jaswal (Assistant Professor, Anaesthesiology).
新型冠状病毒肺炎(COVID-19)现已成为大流行病。它于2019年12月从中国武汉开始传播,并在三个月内蔓延至众多国家。这项工作的目的是报告印度在COVID-19患者的流行病学和临床特征以及管理方面的初步经验。这是一个描述性病例系列,涵盖了2020年2月1日至2020年3月19日期间,在印度一家三级医疗中心确诊感染新型冠状病毒肺炎且经聚合酶链反应(PCR)检测呈阳性的首批21例患者。收集了临床、实验室和放射学数据,包括年龄、性别、国籍、旅行史、症状、住院时间和合并症。患者的平均年龄为40.3岁,男性居多。13例(62%)患者在过去30天内有近期印度境外旅行史,其中三分之二前往了意大利。最常见的症状是发热和咳嗽(42.9%),其次是咽痛、头痛和呼吸困难。所有患者的生命体征和实验室指标均保持正常,无一例需要通气支持。在印度首批21例确诊感染COVID-19的患者中,典型的临床表现为轻度上呼吸道感染,主要影响年轻男性群体。1例患者需要补充氧气。所有患者均康复,无残留症状。
*萨夫达容医院2019年新型冠状病毒肺炎工作组:尼泰什·古普塔、苏米塔·阿格拉瓦尔、普拉纳夫·伊斯、苏鲁奇·米什拉、拉吉尼·盖恩德、加纳帕蒂·乌莎、巴尔文德·辛格、马纳斯·卡迈勒·森、什布达斯·恰克拉巴蒂(肺科顾问兼主任);NK·古普塔(肺科教授);迪帕克·巴塔查里亚(肺科顾问);罗希特·库马尔(肺科助理教授);西达尔特·R·亚达夫(肺科助理教授);鲁希卡·萨克塞纳(微生物学专家);罗贾琳·达斯(微生物学助理教授);维克拉姆吉特·杜塔(微生物学助理教授);阿努帕姆·克尔·安韦希(微生物学高级住院医师);桑塔纳·科利(麻醉学助理教授);纳文·KV(麻醉学助理教授);阿曼迪普·贾斯瓦尔(麻醉学助理教授)